Silexion Therapeutics Corp
SLXN· Nasdaq
SLXNSilexion Therapeutics Corp
Filed May 15, 2026 · 10-Q · 45 days after period end · 0001178913-26-002744
| Metric | Q1 2026 | Q1 2025 | Q1 2024 |
|---|---|---|---|
| Net Income | -$2.73M | -$1.74M | -$1.42M |
| EPS Diluted | $0.85 | $3.84 | $12.29 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Silexion Therapeutics Corp · CIK 2022416 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 15, 2026 · 45 d after period end
